Skip main navigation

You do not have any saved searches

  • Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension

  • Inflammatory Mediators and the Failing Heart: Past, Present, and the Foreseeable Future

  • Early and Repetitive Stimulation of the Arm Can Substantially Improve the Long-Term Outcome After Stroke: A 5-Year Follow-up Study of a Randomized Trial

  • Effects of Clopidogrel and Aspirin in Combination Versus Aspirin Alone on Platelet Activation and Major Receptor Expression in Patients After Recent Ischemic Stroke: For the Plavix Use for Treatment of Stroke (PLUTO-Stroke) Trial

  • Comparison of the National Institutes of Health Stroke Scale With Disability Outcome Measures in Acute Stroke Trials

  • Efficacy of B Vitamins in Lowering Homocysteine in Older Men: Maximal Effects for Those With B12 Deficiency and Hyperhomocysteinemia

  • Abstract 295: The Stem Cell Therapy to Prevent Expansion of Abdominal Aortic Aneurysm (STOP-AAA) Trial: Rationale and Design

    • Michael P Murphy
    • The Investigators of the Cardiovascular Cell Therapy Rsch Network
  • Abstract 206: Randomized Double Blind Clinical Trial on the Effect of Oral Alpha-cyclodextrin on Serum Lipids

  • Biomarkers: A Challenging Conundrum in Cardiovascular Disease

  • Cholesteryl Ester Transfer Protein Inhibition Is Not Yet Dead—Pro

  • The High-Density Lipoprotein Puzzle: Why Classic Epidemiology, Genetic Epidemiology, and Clinical Trials Conflict?

  • Ezetimibe Increases Endogenous Cholesterol Excretion in Humans

  • Endogenous Cholesterol Excretion Is Negatively Associated With Carotid Intima–Media Thickness in Humans

  • Effects of Increasing Exercise Intensity and Dose on Multiple Measures of HDL (High-Density Lipoprotein) Function

  • CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients

  • Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial

  • Abstract 15978: The Lifestyle Physical Activity for Sedentary Older Women (LPAW) Study: Primary Outcomes From a Randomized Controlled Clinical Trial

  • Evaluation and Reduction of Asymptomatic Cerebral Embolism in Ablation of Atrial Fibrillation, But High Prevalence of Chronic Silent Infarction: Results of the Evaluation of Reduction of Asymptomatic Cerebral Embolism Trial

    and on behalf of the ERACE Investigators
  • The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism

    and the HARMONY Investigators*